IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Cancer Genomics & Proteomics


ONLINE ISSN: 1790-6245new_highwire_logo


Cancer Genomics & Proteomics (CGP) is an international online-only open access, peer reviewed bimonthly journal devoted to the rapid publication of original high quality articles and reviews on the applications of genomic and proteomic technology to experimental and clinical cancer research. CGP was established in 2004.

Impact factor (2021): 3.395

Total cites: 1,640

Special Issue on Emerging Technologies in Cancer Research

High-throughput genomic technologies continuously advance and offer new opportunities to better understand and treat cancer. The past decade has seen a plethora of next-generation sequencing and data analysis studies, allowing us to map the genomic landscapes of various cancer types, while single cell analyses are shedding light on tumor heterogeneity. Groundbreaking new technologies, such as spatial omics, can give us unprecedented insight into the spatiotemporal tumor architecture and micro-environment. In this regard, this special issue aims to bring together review articles, experimental and clinical studies on the following topics:

– Whole-genome sequencing
– Single-cell genomics
– Mutational signatures
– Spatial transcriptomics
– Epigenomics
– Multi-omics
– Tumor architecture
– Tumor progression
– Data analysis methods / bioinformatics /machine learning
– Tumor heterogeneity
– Circulating tumor cells
– Precision medicine
– Tumor microenvironment interactions
– Computational immunology
– New therapeutic targets

Publication date: December 1, 2023; Submission deadline: November 3, 2023.
Instructions for the preparation and submission of reviews and original articles.

Our special issue of CANCER GENOMICS AND PROTEOMICS on ‘DNA Replication, Genome Stability and Cell Cycle Control” is now online!

Click here to see the contents

Cancer Genomics & Proteomics is published online-only with open-access through HighWire Press.

Contents of Current Issue
  • 2004 – 2022
  • 19 volumes
  • over 8,500 pages
  • over 630 open access original articles
  • 108 open access reviews
  • over 3,800 authors
  • conference abstracts
  • included in all abstracting services
  • online open access with HighWire Press
  • safe processing of all submitted manuscripts
  • rapid publication within 1-2 months of acceptance
  • no fees for language and style corrections
  • immediate contact with the Editorial Office

111 Bay Avenue, Highlands, NJ 07732, USA.

Information – Editorial & Production Office:
Managing Editor: G. J. Delinasios, International Institute of Anticancer Research,
1st km Kapandritiou- Kalamou Rd., P.O.Box 22, Kapandriti, Attiki 19014, Greece.
Tel & Fax : +30-22950-52945, +30-22950-53389

IMPORTANT NOTE: You may submit your article only through our online submission system